Intervention
PLACEBO
ClinicalTrials.gov intervention label
Clinical trials
26 shownEvaluation of the Impact of Taking American Ginseng for 8 Weeks on Fatigue in Patients Treated for Localized Breast or Gynecological CancerNCT05241405 · 2022-09-27
RECRUITINGCranberry for the Prevention of Urinary Tract InfectionsNCT05730998 · 2022-09-01
COMPLETEDResearch Study Investigating Study Medicine (NNC9204-1177) for Weight Management in People With Overweight or ObesityNCT03308721 · 2017-10-16
COMPLETEDComparative Evaluation Of 1.2% Atorvastatin and 1.2% Simvastatin Gel Local Drug Delivery And Redelivery In Chronic Periodontitis Subjects With Diabetes Mellitus: A Randomized Controlled Clinical Trial.NCT03745300 · 2017-03-03
COMPLETEDEffects of Dual Bronchodilator Treatment on Cardiopulmonary Interactions in COPDNCT03425617 · 2017-01-01
COMPLETEDEffect of MD1003 in Progressive Multiple Sclerosis (SPI2)NCT02936037 · 2016-12-01
TERMINATEDTargeting Inflammation With Salsalate in Type 1 Diabetes NeuropathyNCT02936843 · 2016-10-01
COMPLETEDImpact of Antichlamydial Treatment on the Rate of PreeclampsiaNCT03233880 · 2016-07-01
UNKNOWNA Clinical Trial to Evaluate the Safety and Efficacy of Traditional Chinese Medicine in Sjögren's Syndrome.NCT04111341 · 2016-05-06
COMPLETEDEffects of Pitavastatin on Insulin Sensitivity and Liver FatNCT02290106 · 2015-03-02
COMPLETEDATP in Alzheimer DiseaseNCT02279511 · 2014-12-01
COMPLETEDA Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Dose-Response Relationship of Multiple Doses of GSK2269557 Administered as a Dry Powder to Chronic Obstructive Pulmonary Disease (COPD) PatientsNCT02130635 · 2014-07-31
COMPLETEDEfficacy Of Bacterial Lysate In Asthmatic ChildrenNCT02541331 · 2014-07-01
COMPLETEDA Global Study to Assess the Effects of MEDI4736 Following Concurrent Chemoradiation in Patients With Stage III Unresectable Non-Small Cell Lung CancerNCT02125461 · 2014-05-07
COMPLETEDEfficacy and Safety Study of MYOBLOC® in the Treatment of Sialorrhea in Adult SubjectsNCT01994109 · 2013-11-01
COMPLETEDA Phase II, Randomized, Double-blind, Placebo-controlled, in Parallel Groups Clinical Trial to Assess the Safety and Efficacy of Dietary Supplementation With Tryptophan to Achieve Weight Loss, and Its Neuropsychological Effects in Adolescents With ObesityNCT02612259 · 2012-01-01
COMPLETEDEffects of Cholecalciferol Supplementation in Patients With Chronic Heart Failure and LOw vITamind D LevelsNCT01477801 · 2011-11-01
UNKNOWNDPP-4 Inhibition and TZD for DM PreventionNCT01006018 · 2011-07-01
TERMINATEDPasireotide LAR Administration in Lymphocele Prevention After Axillary Node Dissection for Breast CancerNCT01356862 · 2010-09-01
COMPLETEDFirst Time in Human StudyNCT01031186 · 2009-11-23
COMPLETEDEffects of Docosahexaenoic Acid (DHA) on Children With Nonalcoholic Fatty Liver Disease (NAFLD)NCT00885313 · 2009-03-01
COMPLETEDPENNVAX-B With or Without IL-12 or IL-15 as a DNA Vaccine for HIV InfectionNCT00775424 · 2008-09-01
COMPLETEDA Phase 2A Study to Evaluate the Safety and Effect on Exercise Challenge Testing of MEDI-528 in Adults With AsthmaNCT00590720 · 2008-03-01
TERMINATEDEffect of All-trans Retinoic Acid With Chemotherapy Based in Paclitaxel and Cisplatin as First Line Treatment of Patients With Advanced Non-small Cell Lung CancerNCT01048645 · 2007-09-01
COMPLETEDA Study to Evaluate the Safety and Tolerability of the Administration of MEDI-528 When Administered in Multiple Doses to Adults With Mild Persistent AsthmaNCT00507130 · 2007-07-01
COMPLETEDA Study to Evaluate the Effect of a Single-Dose Intravenous Administration of MEDI-528NCT00483041 · 2007-07-01
TERMINATEDCommon conditions
Obesity4Asthma3Breast Cancer2Allergic Asthma1Alzheimer's Disease1Chronic Obstructive Pulmonary Disease1Chronic Periodontitis Wth Diabetes Mellitus1Depressive Disorder and Anxiety Disorders1Diabetes1Fatigue1Fatty Liver1Fatty Liver, Nonalcoholic1Heart Failure1HIV Infection1Liver Fibrosis1Metabolic Syndrome1Metabolism and Nutrition Disorder1Multiple Sclerosis1Non-Small Cell Lung Cancer1Non-Small-Cell Lung Carcinoma1Nonalcoholic Fatty Liver Disease1Peripheral Neuropathy1Pre-Eclampsia1Prediabetic State1Pulmonary Disease, Chronic Obstructive1
Leading sponsors
MedImmune LLC3GlaxoSmithKline2Ain Shams Maternity Hospital1Alliance Pour La Recherche en Cancerologie1AstraZeneca1Azienda di Servizi alla Persona di Pavia1Azienda Unita' Sanitaria Locale Di Modena1Bambino Gesù Hospital and Research Institute1Centre Francois Baclesse1Chung Shan Medical University1Emory University1Fundació Sant Joan de Déu1Government Dental College and Research Institute, Bangalore1Lallemand Pharma AG1Massachusetts General Hospital1
Trial status mix
COMPLETED19
TERMINATED4
UNKNOWN2
RECRUITING1
Phase mix
PHASE213
PHASE37
NA4
PHASE14
PHASE42
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.